CAPILLARY
Capillary Technologies India Limited (capillary) Appoints Bill Swift as President, Americas
Capillary Technologies India Limited (CAPILLARY) appoints Bill Swift as President, Americas, strengthening its US leadership and growth strategy.
Capillary Technologies India Limited (CAPILLARY) announced the appointment of Bill Swift as President, Americas, on October 29, 2026. This strategic move underscores Capillary’s commitment to deepening its presence across the Americas. Swift brings nearly 30 years of experience in helping leading brands build lasting customer relationships and drive measurable business results.
Leadership Expertise
Swift previously served as CEO of Brierley, a company that pioneered in loyalty solutions. His role at Brierley+Partners, where he helped create a successful loyalty platform, has equipped him with deep insights into loyalty strategies. Since joining Capillary in 2023, Swift has been instrumental in integrating acquisitions and shaping Capillary’s growth trajectory.
Strategic Vision for Americas
In his new role, Swift will lead Capillary’s business operations across the Americas, focusing on sales, client success, and delivery. He aims to drive growth with enterprise brands in retail, hospitality, travel, airlines, and other major sectors. Swift emphasizes that loyalty should be viewed as a catalyst for growth, facilitated by technology that delivers powerful customer experiences and business results.
“Loyalty has always been about earning the right to a lasting relationship with the customer,” said Bill Swift. “The most successful brands now see loyalty as a catalyst for growth, driven by technology that delivers real business results.”
Anant Choubey, co-founder & COO of Capillary, highlighted Swift’s strategic depth and understanding of customer relationships, stating, “His leadership was essential to Brierley+Partners’ success, and he is the right leader to accelerate our growth across the Americas.”
Founded in 2012, Capillary Technologies helps brands leverage lasting customer relationships to achieve measurable growth. Its AI-powered platform integrates loyalty, data, and engagement to deliver personalized experiences, strengthening retention and growing customer lifetime value.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Capillary Technologies India Limited
Capillary Technologies India Limited belongs to the Technology › Software – Application sector. Here’s a quick read on where the business and the stock stand today.
Capillary rises 11.0% over three months, with buying pressure holding steady. Thin margins at 5.2% leave limited room for error — any demand softness or cost spike hits the bottom line hard. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. The stock holds at 30% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) eases after clearing resistance, down 5% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) shows pressure after breakout, moving down 5% intraday.
Capillary Technologies India Limited (CAPILLARY) pulls back from breakout highs, falling 5% to ₹530.4 on the NSE today. This retracement comes after the stock cleared a crucial 6-month resistance level at ₹512, marking a structural breakout. The pullback today is likely due to profit-taking following this breakout. Capillary Technologies operates in the technology sector, specifically in software infrastructure. Today’s move appears to be company-specific rather than a sector-wide trend, as it follows the breakout and subsequent profit-taking.
Technical setup — trendlines & DMA
The current 6-month trendline structure shows a breakout above the resistance level at ₹512, with the stock now trading 3.5% above this resistance. The 6-month support trendline is at ₹464.21, which is 12.48% below today’s price. The stock is currently trading 11% above the 50-day moving average (DMA) at ₹505.2, indicating an extended move. However, it is slightly below the 200-DMA at ₹560.7. The stock is in the lower third of its 52-week range, trading 20% above the 52-week low and 33.6% below the 52-week high, suggesting there is still room for further upside within the year.
Snapshot: ₹530.40 on 2026-08-10 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 81.7 and profit margins at 5.2%, Capillary Technologies is trading at a high valuation relative to its current earnings. The revenue CAGR of 34.0% indicates strong growth, but the thin profit margins suggest that the market may be pricing in future improvements or a potential turnaround. The 20.6% institutional ownership suggests that smart money has a moderate level of confidence in the company, though it is not overwhelmingly bullish. There is no NSE catalyst today, so the move is primarily technical.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically strong but fundamentally weak position for Capillary Technologies. The strongest signals include the revenue and profit CAGRs, which are excellent at 34.0% and 27.0%, respectively, indicating robust growth. Additionally, the very low debt level with a D/E ratio of 0.00 points to excellent financial health. On the weaker side, the low profit margin of 5.2% leaves little room for error, and the PEG ratio of 3.03 suggests the stock is overvalued relative to its growth rate. The negligible dividend yield also means there is little to no income generation from this investment.
Company outlook
Management expects EBITDA margins to remain sustainable, with a potential dip due to the SessionM acquisition. The core organic business is projected to reach a steady-state EBITDA margin of 25-30%. Revenues are anticipated to exceed INR 1,000-1,050 crores in FY27, driven by both the SessionM acquisition and organic growth. SessionM is expected to significantly contribute to revenue growth and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) gains 10% intraday, breaks out
Capillary Technologies India Limited (CAPILLARY) stock gains 10% intraday, breaking out from its 6M resistance trendline.
Capillary Technologies India Limited (CAPILLARY) breaks out, gaining +10% to ₹589.4 on the NSE on 05 Aug 2026, backed by its Q1 FY2027 results showing a 43% revenue increase and a 132% surge in adjusted EBITDA. This move is company-specific, driven by strong financial performance rather than sector-wide momentum. Capillary Technologies, a player in the technology sector focusing on software infrastructure, has shown remarkable growth, distinguishing itself from broader market trends.
Technical setup — trendlines & DMA
From a technical standpoint, CAPILLARY has cleared its 6-month resistance trendline, currently standing at ₹511.86, marking a breakout. The stock is now trading 13.16% above this resistance level, indicating strong upward momentum. The 6-month support trendline is at ₹466.56, which is 20.84% below the current price, providing a solid floor. The 50-day moving average (DMA) at ₹504.1 is below the 200-DMA at ₹561.1, suggesting a bearish trend in the short term but a bullish trend in the long term. CAPILLARY is currently in the middle third of its 52-week range, which spans from ₹464.2 to ₹799.0, implying there is room for further upside.
Snapshot: ₹589.40 on 2026-08-05 (chart frozen at publication)
Fundamentals & business context
Fundamentally, CAPILLARY presents a mixed picture. With a PE ratio of 78.0 and profit margins at 7.1%, the valuation appears stretched relative to current earnings, especially given the thin profit margins. However, the revenue CAGR of 42.2% over the past five years indicates strong growth potential. Institutional ownership stands at 20.6%, suggesting that smart money has a moderate level of confidence in the company. The recent NSE filing highlights a robust quarter with significant revenue and EBITDA growth, reinforcing the positive sentiment around the stock.
Algorithmic scorecard
The algorithmic scorecard reflects a technically strong but fundamentally weaker profile for CAPILLARY. The breakout above resistance and the bullish sentiment over the last 30 days, with an 8.57x higher average volume on up days compared to down days, signal strong accumulation and positive market sentiment. However, the low profit margin of 7.1% and the negligible dividend yield of 0% represent significant risks. The company’s excellent revenue growth consistency and very low debt level are strong positives, but the declining profit CAGR and lack of dividend income could be concerns for income-focused investors.
Company outlook
Management’s forward guidance for Capillary Technologies is optimistic, with expectations for EBITDA margins to remain sustainable, despite a potential dip due to the SessionM acquisition. The company anticipates core organic business margins to reach a steady-state of 25-30% EBITDA margin. Revenues are projected to exceed INR 1,000-1,050 crores in FY27, driven by both organic growth and the SessionM acquisition. SessionM is expected to significantly contribute to revenue and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to enhance margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
CAPILLARY
Capillary Technologies India Limited (CAPILLARY) breaks out, gains 7% intraday
Capillary Technologies India Limited (NSE: CAPILLARY) stock breaks out, gaining 7% intraday to ₹572.7, backed by strong Q1 FY2027 results.
Capillary Technologies India Limited (CAPILLARY) breaks out, gaining +7% to ₹572.7 on the NSE on 05 Aug 2026, backed by its Q1 FY2027 results showing a 43% revenue increase. This move is driven by the company’s strong financial performance, which has cleared its 6-month resistance trendline after a period of consolidation. Capillary Technologies, a player in the technology sector specializing in software infrastructure, has shown a company-specific surge rather than aligning with broader sector momentum.
Technical setup — trendlines & DMA
The current 6-month trendline structure shows a breakout above the resistance level of ₹511.86, with the stock now trading 10.62% above this point. The 6-month support floor is at ₹466.56, which is 18.53% below today’s price, indicating a strong upward move. The 50-day moving average (DMA) is at ₹504.1, while the 200-DMA is at ₹561.1, showing that the stock is trading above the 50-DMA but still below the 200-DMA. This suggests a mixed position in terms of moving averages. The stock is currently in the lower third of its 52-week range, indicating that there may be room for further upside as it has only recovered 32% from its 52-week low.
Snapshot: ₹572.70 on 2026-08-05 (chart frozen at publication)
Fundamentals & business context
With a PE ratio of 78.0, Capillary Technologies is trading at a high valuation relative to its profit margin of 7.1%, which suggests that the market may be pricing in future growth rather than current earnings. The company’s revenue CAGR of 42.2% over the past five years indicates strong growth, but the absence of profit CAGR suggests that this growth has not yet translated into consistent profitability. The 20.6% institutional ownership reflects a cautious yet interested stance from the smart money, possibly indicating a balance between growth potential and risk. Today’s move is directly linked to the strong Q1 FY2027 results, which served as a clear catalyst.
Algorithmic scorecard
The overall algorithmic scorecard reflects a technically strong but fundamentally weaker profile for Capillary Technologies. The strongest signals come from the breakout above resistance levels with momentum, indicating a positive technical setup, and the consistent revenue growth every year, which points to exceptional business stability. On the weaker side, the low profit margin of 7.1% leaves little room for error, and the negligible dividend yield offers little to no income for investors. These factors highlight the risk of thin profits and the lack of income generation through dividends.
Company outlook
Capillary Technologies has provided forward guidance indicating that revenues are expected to cross INR 1,000-1,050 crores in FY27, driven by the SessionM acquisition and organic growth. The company expects EBITDA margins to remain at sustainable levels, with a core organic business moving towards a steady-state EBITDA margin of 25-30%. SessionM is expected to deliver significant revenue growth and EBITDA contributions in the coming years. The company plans to maintain a focus on a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. Additionally, Capillary Technologies intends to develop an AI-led platform to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.
Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.
-
RAYMONDREL3 days agoRaymond Realty Limited (raymondrel) Secures ₹210 Crore Investment for Ten X Realty West
-
Auto Parts3 days agoSona BLW Precision Forgings Limited Q2 FY27 Results: Record Revenue, Ebitda, and PAT
-
ANTELOPUS3 days agoAntelopus Selan Energy Limited Q2fy’27 Results: Revenue Up 123%, Net Profit Surges 414%
-
Auto Parts3 days agoLumax Industries Limited (lumaxind) Q2fy27: Revenue Up 33%, PAT Surges 46%
-
Basic Materials3 days agoChemcon Speciality Chemicals Limited Q2 FY27: Revenue Up 22%, PAT Surges 31%
-
BRIGHOTEL3 days agoBrigade Hotel Ventures Limited (brighotel) Q2 FY27: PAT More Than Doubles
-
Conglomerates3 days agoDcm Shriram Limited (dcmshriram) Q2 FY27: 22% Revenue Growth at ₹3,977 Crore
-
KFINTECH3 days agoKfin Technologies Limited Q2fy27: Strong Performance Driven by Broad-based Revenue Growth and Margin Expansion